AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Paysign, Inc.
Video analysis: PAYS
All videosNo video analysis for this stock yet. Request one from our team.
News: PAYS
BlackRock Inc. Buys Shares of 3,079,208 Paysign, Inc. $PAYS
BlackRock Inc. bought a new position in Paysign, Inc. (NASDAQ: PAYS) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,079,208 shares of the company's stock, valued at approximately $25,219,000. BlackRock Inc. owned about 5.51% of Paysign as of its
Paysign Targets $117M Revenue as Patient-Affordability Business Surges
Paysign NASDAQ: PAYS operates in two healthcare-focused businesses: payment services for plasma donors and pharmaceutical patient-affordability programs, Chief Financial Officer Jeff Baker said during a company presentation.
Paysign (PAYS) is an Incredible Growth Stock: 3 Reasons Why
Paysign (PAYS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Paysign (PAYS) Upgraded to Buy: What Does It Mean for the Stock?
Paysign (PAYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Are Business Services Stocks Lagging Paysign (PAYS) This Year?
Here is how Paysign, Inc. (PAYS) and Sezzle Inc. (SEZL) have performed compared to their sector so far this year.
Paysign, Inc. $PAYS Shares Acquired by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP increased its stake in shares of Paysign, Inc. (NASDAQ: PAYS) by 16.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 575,619 shares of the company's stock after purchasing an additional 82,736 shares during
3 Reasons Growth Investors Will Love Paysign (PAYS)
Paysign (PAYS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Paysign Q2 Earnings Call Highlights
Paysign NASDAQ: PAYS reported record second-quarter revenue, net income and adjusted EBITDA for 2026, driven primarily by continued expansion in its Patient Affordability business and improving utilization in its plasma donor compensation operations.
